BioCentury | Mar 10, 2017
Financial News

Easton Pharmaceuticals completes debt financing

...On March 3, cancer, dermatology and drug delivery company Easton Pharmaceuticals Inc. (Pink:EAPH) drew down C$600,000 ($448,320) of...
...of a new C$2 million ($1.5 million) secured convertible loan facility. Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Alex Himes Easton Pharmaceuticals Inc....
BioCentury | Jan 11, 2016
Company News

Easton Pharmaceuticals, XL-protein deal

...milestones, plus tiered mid- to mid-high-single-digit royalties. The companies did not to respond to inquiries. Easton Pharmaceuticals Inc....
BioCentury | Jun 10, 2013
Company News

Easton Pharmaceuticals management update

Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Hired: Neil Mellor as a senior consultant and COO WIR Staff Dermatology...
BioCentury | Jun 27, 2011
Company News

Easton Pharmaceuticals management update

Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Hired: Jack Barkin as SVP and CMO, currently an assistant professor at the University of Toronto WIR Staff Dermatology...
BioCentury | Jun 20, 2011
Company News

Easton Pharmaceuticals management update

Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Transitioned: John Easton to interim CEO, while remaining chairman; he succeeds Walter Folinski, who will remain president WIR Staff Dermatology...
BioCentury | Aug 19, 2002
Company News

LAM Pharmaceuticals Corp. sales and marketing update

...LAMP launched its L.A.M. IPM Wound Gel , an ionic polymer matrix containing sodium hyaluronate, to...
BioCentury | Oct 11, 1999
Clinical News

Ionic Polymer Matrix-based compounds regulatory update

...LAMP received U.S. Patent No. 5,952,006 covering topical ionic polymer matrix compounds to treat impotency. L.A.M....
BioCentury | Sep 7, 1999
Clinical News

Ionic Polymer Matrix drug delivery system regulatory update

...LAMP received U.S. Patent No. 5,897,880 covering its Ionic Polymer Matrix transdermal drug delivery system. L.A.M....
Items per page:
1 - 8 of 8
BioCentury | Mar 10, 2017
Financial News

Easton Pharmaceuticals completes debt financing

...On March 3, cancer, dermatology and drug delivery company Easton Pharmaceuticals Inc. (Pink:EAPH) drew down C$600,000 ($448,320) of...
...of a new C$2 million ($1.5 million) secured convertible loan facility. Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Alex Himes Easton Pharmaceuticals Inc....
BioCentury | Jan 11, 2016
Company News

Easton Pharmaceuticals, XL-protein deal

...milestones, plus tiered mid- to mid-high-single-digit royalties. The companies did not to respond to inquiries. Easton Pharmaceuticals Inc....
BioCentury | Jun 10, 2013
Company News

Easton Pharmaceuticals management update

Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Hired: Neil Mellor as a senior consultant and COO WIR Staff Dermatology...
BioCentury | Jun 27, 2011
Company News

Easton Pharmaceuticals management update

Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Hired: Jack Barkin as SVP and CMO, currently an assistant professor at the University of Toronto WIR Staff Dermatology...
BioCentury | Jun 20, 2011
Company News

Easton Pharmaceuticals management update

Easton Pharmaceuticals Inc. (Pink:EAPH), Toronto, Ontario Business: Drug delivery, Dermatology Transitioned: John Easton to interim CEO, while remaining chairman; he succeeds Walter Folinski, who will remain president WIR Staff Dermatology...
BioCentury | Aug 19, 2002
Company News

LAM Pharmaceuticals Corp. sales and marketing update

...LAMP launched its L.A.M. IPM Wound Gel , an ionic polymer matrix containing sodium hyaluronate, to...
BioCentury | Oct 11, 1999
Clinical News

Ionic Polymer Matrix-based compounds regulatory update

...LAMP received U.S. Patent No. 5,952,006 covering topical ionic polymer matrix compounds to treat impotency. L.A.M....
BioCentury | Sep 7, 1999
Clinical News

Ionic Polymer Matrix drug delivery system regulatory update

...LAMP received U.S. Patent No. 5,897,880 covering its Ionic Polymer Matrix transdermal drug delivery system. L.A.M....
Items per page:
1 - 8 of 8